Stromal cell-derived factors in Duchenne muscular dystrophy

Acta Myologica

Volumn 29, Issue DECEMBER, 2010, Pages 398-403

  Abdel Salam, Ekram ^a   Ehsan Abdel Meguid, I ^a   Shatla, R ^b   Korraa, S S ^c  

^a CAIRO UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY   (Egypt)

Author keywords

Duchenne dystrophy; EPCs surface receptors; Stromal cell derived factors

Indexed keywords

CD133 ANTIGEN; CD34 ANTIBODY; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENE EXPRESSION; HUMAN; MALE; MONONUCLEAR CELL; MUSCLE ISCHEMIA; MUSCLE REGENERATION; MUSCLE TISSUE; STEM CELL;

ANTIGENS, CD; ANTIGENS, CD34; CELL MOVEMENT; CHEMOKINE CXCL12; CHILD; ENDOTHELIAL CELLS; FEMALE; GLYCOPROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MUSCULAR DYSTROPHY, DUCHENNE; PEPTIDES; REGENERATION; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 79955762802     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Emery A. The muscular dystrophies. Lancet 2002;359:687-95. (Pubitemid 34203773)
2. Moser H. Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention. Hum Genet 1984;66:17-40. (Pubitemid 14159042)
3. Cullen M, Mastaglia F. Morphological changes in dystrophic muscle. Br Med Bull 1980;36:145-52. (Pubitemid 10060583)
4. Finsterer J, Stollberger C. The heart in human dystrophinopathies. Cardiology 2003;99:1-19. (Pubitemid 36206630)
5. Yotsukura M, Fujii K, Katayama A, et al. Nine-year follow-up study of heart rate variability in patients with Duchenne-type progressive muscular dystrophy. Am Heart J 1998;136:289-96. (Pubitemid 28368852)
6. Yotsukura M, Sasaki K, Kachi E, et al. Circadian rhythm and variability of heart rate in Duchenne-type progressive muscular dystrophy. Am J Cardiol 1995;76:947-51.
7. Hunsaker R, Fulkerson P, Barry F, et al. Cardiac function in Duchenne's muscular dystrophy: Results of 10-year follow-up study and noninvasive tests. Am J Med 1982;73:235-8. (Pubitemid 13203921)
8. Kaspar R, Allen H, Montanaro F. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy. J Am Acad Nurse Pract 2009;21:241-9.
9. Marti V, Aymat R, Ballester M, et al. Coronary endothelial dysfunction and myocardial cell damage in chronic stable idiopathic dilated cardiomyopathy. Int J Cardiol 2002;82:237-45. (Pubitemid 34241579)
10. Roura S, Planas F, Prat-Vidal C, et al. Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation. Eur J Heart Fail 2007;9:995-1002. (Pubitemid 47451812)
11. Lin Y, Weisdorf D, Solovey A, et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-7. http://circ.ahajournals.org/cgi/external-ref?access-num=10619863&link-type= MED (Pubitemid 30036389)
12. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 2000;95:952-8. (Pubitemid 30062717)
13. Urbich C, Heeschen C, Aicher A, et al. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 2003;108:2511-6. (Pubitemid 37444414)
14. Fujiyama S, Amano K, Uehira K, et al. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res 2003;10:980-9. (Pubitemid 37433236)
15. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:e1-e7.
16. Hill J, Zalos G, Halcox J, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
17. Taguchi A, Matsuyama T, Moriwaki H, et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 2004;109:2972-5. (Pubitemid 38808318)
18. Thijssen D, Vos J, Verseyden C, et al. Haematopoietic stem cells and endothelial progenitor cells in healthy men: effect of aging and training. Aging Cell 2006;5:495-503. (Pubitemid 44782618)
19. Kucia M, Reca R, Miekus K, et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: Pivotal role of SDF-1-CXCR4 axis. Stem Cells 2005;23:879-94. (Pubitemid 41170944)
20. Hattori K, Heissig B, Tashiro K, et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001;97:3354-60.
21. Tomita S, Mickle D, Weisel R, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 2002;123:1132-40.
22. Yamaguchi J, Kusano KF, Masuo O, et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003;107:1322-8. (Pubitemid 36314418)
23. Semenza G. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology (Bethesda) 2009;24:97-106.
24. 2 tension. Proc Natl Acad Sci USA 1995;92:5510-4.
25. Straino S, Germani A, Di Carlo A, et al. Enhanced arteriogenesis and wound repair in dystrophin-deficient mdx mice. Circulation 2004;110:3341-8. (Pubitemid 39557497)
26. Stellos K, Bigalke B, Langer H, et al. Expression of stromal-cell-derived factor on circulating platelets is increased in patients with acute coronary syndrom and correlates with the number of CD34+ progenitor cells. Eur Heart J 2009;30:584-93.
27. Nakamura H, Makino Y, Okamoto K, et al. TCR engagement increases hypoxia-inducible factor-1 alpha protein synthesis via rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells. J Immunol 2005;174:7592-9. (Pubitemid 40806263)
28. Jin CZ, Zhao Y, Zhang FJ, et al. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China. Chin Med J (Engl). 2009 Mar 5;122 (5):530-5
29. Li Y, Zhang C, Xiong F, et al. Comparative study of mesenchymal stem cells from C57BL/10 and mdx mice. BMC Cell Biol 2008;9:24-35.
30. Badorff C, Brandes R, Popp R, et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003;107:1024-32. (Pubitemid 36258727)
31. Iwasaki H, Kawamoto A, Ishikawa M, et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 2006;113:1311-25. (Pubitemid 43739453)
32. Jankowski R, Deasy B, Cao B, et al. The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J Cell Sci 2002;115:4361-74. (Pubitemid 35460706)
33. Marchesi C, Belicchi M, Meregalli M, et al. Correlation of Circulating CD133+ Progenitor Subclasses with a Mild Phenotype in Duchenne Muscular Dystrophy Patients. PLoS ONE. 2008;3: e2218.
34. Tondreau T, Meuleman N, Delforge A, et al. Mesenchymal Stem Cells Derived from CD133-Positive Cells in Mobilized Peripheral Blood and Cord Blood: Proliferation, Oct4 Expression, and Plasticity. Stem Cells 2005;23:1105-12. (Pubitemid 41377726)
35. Sasaki H, Ishikawa M, Tanaka N, et al. Administration of human peripheral blood-derived CD133+ cells accelerates functional recovery in a rat spinal cord injury model. Spine 2009;34:249-54.
36. Kijima Y, Ishikawa M, Sunagawa T, et al. Regeneration of peripheral nerve after transplantation of CD133+ cells derived from human peripheral blood. J Neurosurg 2009;110:758-67.
37. Torrente Y, Belicchi M, Sampaolesi M, et al. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 2004;114:182-95. (Pubitemid 39071623)
38. Nico B, Mangieri D, Crivellato E, et al. HIF activation and VEGF overexpression are coupled with ZO-1 up-phosphorylation in the brain of dystrophic mdx mouse. Brain Pathol 2007;17:399-406. (Pubitemid 47537597)
39. Shantsila E, Watson T, Lip G. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 2007;49:741-52.
40. Csaky KG, Baffi JZ, Byrnes GA, et al. Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor. Exp Eye Res. 2004;78:1107-16. (Pubitemid 38510348)
41. Hattori K, Heissiq B, Tashiro K, et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001;97:3354-60.
42. Gupta S, Lysko P, Pillarisetti K, et al. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 1998:273:4282-7. (Pubitemid 28103301)
43. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858-64. (Pubitemid 39070860)
44. Ben-Shoshan J, Schwartz S, Luboshits G, et al. Constitutive expression of HIF-lalpha and HIF-2alpha in bone marrow stromal cells differentially promotes their proangiogenic properties. Stem Cells. 2008;26:2634-43.
45. Du R, Lu KV, Petritsch C, et al. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008;13:206-20. (Pubitemid 351318372)
46. Unoki N, Murakami T, Nishijima K, et al. SDF-1/CXCR4 contributes to the activation of tip cells and microglia in retinal angiogenesis. Invest Ophthalmol Vis Sci 2010;51:3362-71.
47. Perez A, Bachrach E, Illigens B, et al. CXCR4 enhances engraftment of muscle progenitor cells. Muscle Nerve 2009;40:562-72.
48. Ceradini D, Kulkami A, Callaghan M, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004;10:858-64. (Pubitemid 39070860)
49. 2 homeostasis by hypoxia-inducible factor 1. Genes Dev 1998;12:149-62. (Pubitemid 28060446)
50. Kelly B, Hackett S, Hirota K, et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003;93:1074-81. (Pubitemid 37485038)
51. 2 homeostasis by hypoxia-inducible factor 1. Genes Dev 1998;12:149-62. (Pubitemid 28060446)
52. Kelly B, Hackett S, Hirota K, et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in non-ischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003;93:1074-81. (Pubitemid 37485038)
53. Manalo D, Rowan A, Lavoie T, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF 1. Blood 2005;105:659-69. (Pubitemid 40070750)
54. Tang N, Wang L, Esko J, et al. Loss of HIF-1 in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 2004;6:485-95. (Pubitemid 39469984)
55. Calvani M, Rapisarda A, Uranchimeg B, et al. Hypoxic induction of an HIF-1-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 2006;107:2705-12.